
Agilent Technologies A
$ 133.33
0.07%
Quarterly report 2025-Q2
added 08-29-2025
Agilent Technologies Cash Conversion Cycle 2011-2026 | A
Annual Cash Conversion Cycle Agilent Technologies
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 111 | 124 | 116 | 106 | 107 | 105 | 103 | 116 | 120 | 111 | 97.8 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 124 | 97.8 | 111 |
Quarterly Cash Conversion Cycle Agilent Technologies
| 2025-Q2 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2023-Q4 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 121 | - | - | - | - | 128 | 57 | - | - | 114 | 114 | - | 115 | 113 | 121 | 43 | 130 | 123 | 115 | 39.5 | 118 | 113 | 110 | 36.1 | 109 | 101 | 110 | 36.3 | 107 | 107 | 109 | 35.6 | 105 | 110 | 105 | 34.4 | 102 | 156 | 152 | 35.5 | 106 | 147 | 118 | 39.9 | 122 | 107 | 112 | 37.5 | 109 | 97.5 | 102 | 33.1 | 95.1 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 156 | 33.1 | 96.8 |
Cash Conversion Cycle of other stocks in the Diagnostics research industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
50.2 | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
275 | $ 3.03 | -2.26 % | $ 98.3 K | ||
|
Trinity Biotech plc
TRIB
|
136 | $ 0.83 | -5.96 % | $ 61.9 M | ||
|
Akumin
AKU
|
36.1 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
-38.7 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
78.1 | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
149 | $ 34.5 | 2.16 % | $ 371 M | ||
|
Accelerate Diagnostics
AXDX
|
364 | - | -61.36 % | $ 2.46 M | ||
|
BioNano Genomics
BNGO
|
225 | $ 1.29 | -12.26 % | $ 1.64 M | ||
|
Castle Biosciences
CSTL
|
45.9 | $ 39.74 | 1.48 % | $ 1.1 B | ||
|
Chembio Diagnostics
CEMI
|
111 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
299 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
83.5 | $ 219.29 | -0.08 % | $ 160 B | ||
|
Exact Sciences Corporation
EXAS
|
130 | $ 102.41 | 0.1 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
42.4 | $ 26.19 | -0.19 % | $ 792 M | ||
|
DermTech
DMTK
|
66.7 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
184 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
142 | - | 0.12 % | $ 80.1 M | ||
|
Guardant Health
GH
|
49.1 | $ 113.17 | 2.43 % | $ 13.9 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.21 K | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
133 | $ 73.31 | -0.93 % | $ 28.3 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 20.55 | -1.23 % | $ 1.1 B | ||
|
DarioHealth Corp.
DRIO
|
207 | $ 10.2 | -0.97 % | $ 289 M | ||
|
Enzo Biochem
ENZ
|
154 | - | -8.98 % | $ 14.8 K | ||
|
Lantheus Holdings
LNTH
|
90.9 | $ 66.91 | 0.34 % | $ 4.63 B | ||
|
Heska Corporation
HSKA
|
138 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
104 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
142 | $ 144.81 | -3.26 % | $ 23 B | ||
|
NeoGenomics
NEO
|
82.3 | $ 11.99 | -3.35 % | $ 1.52 B | ||
|
QIAGEN N.V.
QGEN
|
122 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 230.33 | -2.19 % | $ 41.8 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 210.51 | -0.59 % | $ 10.8 B | ||
|
Personalis
PSNL
|
-11.5 | $ 9.33 | -6.42 % | $ 553 M | ||
|
Medpace Holdings
MEDP
|
51.5 | $ 582.66 | -1.76 % | $ 18 B | ||
|
Quest Diagnostics Incorporated
DGX
|
38.6 | $ 186.45 | 2.27 % | $ 20.7 B | ||
|
Biodesix
BDSX
|
41.7 | $ 10.11 | 4.66 % | $ 1.31 B | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
-3.19 | $ 24.07 | -0.78 % | $ 31.2 M | ||
|
Laboratory Corporation of America Holdings
LH
|
39.8 | $ 271.34 | 0.56 % | $ 22.8 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 370.47 | -1.61 % | $ 29.1 B | ||
|
ICON Public Limited Company
ICLR
|
62 | $ 181.44 | -2.39 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
108 | $ 672.84 | -0.57 % | $ 55.5 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 28.66 | -2.02 % | $ 20 B |